Peptide Reconstitution Calculator: Concentration, Volume and Syringe Units

How reconstitution works

Peptides are usually supplied as a freeze-dried (lyophilized) powder in a sealed glass vial, because most of them break down within days in solution. Reconstitution means adding a sterile diluent to dissolve the powder. For a multi-dose vial the diluent is normally bacteriostatic water for injection, which is sterile water with 0.9 percent benzyl alcohol as a preservative; its product labeling says to discard the water vial 28 days after it is first punctured, and compounding pharmacies apply the same 28-day limit to a reconstituted multi-dose vial unless the pharmacy's own label says otherwise. Plain sterile water for injection has no preservative and is intended for single use.

The milligram figure on the vial is the whole of the peptide, and nothing you add changes it. Water changes only how that weight is spread through a volume, which is why the number of full doses stays the same whether you add 1 mL or 4 mL while the volume of each dose does not. Some vials arrive already reconstituted and labeled by the pharmacy with a concentration and a beyond-use date, in which case there is no choice to make and this page is a check on the label. Where the choice is yours it is made once, before the first dose, because the concentration cannot be altered afterward without the vial being re-dispensed.

Storage, labeling and handling after mixing

Diluent goes in slowly, down the inside wall of the vial, rather than sprayed onto the powder, and the vial is rolled or swirled gently until the solution runs clear. Peptides are not shaken, because foaming and shear can damage them. If the solution stays cloudy, carries visible particles or has changed color, that is a question for the dispensing pharmacy before anything is drawn out of it.

Write the mixing date and the concentration from this page on the vial the moment it is mixed, because every later dose depends on that one number and nobody remembers it three weeks later. Keep the vial refrigerated and out of light, and treat the pharmacy's beyond-use date as the limit rather than a general rule: the 28 days that bacteriostatic water labeling allows is a ceiling set by the preservative, not a stability claim for the peptide inside, and some peptides fall well short of it. Written storage and handling instructions from the clinic or pharmacy that dispensed the vial take precedence over anything general written here.

What one unit holds at 1, 2, 3 and 4 mL

Every unit on a U-100 syringe is 0.01 mL, so one unit holds the concentration divided by 100. Take a 10 mg vial. With 1 mL of water it holds 10,000 mcg/mL and one unit is 100 mcg; with 2 mL, 5,000 mcg/mL and 50 mcg per unit; with 3 mL, about 3,333 mcg/mL and 33 mcg per unit; with 4 mL, 2,500 mcg/mL and 25 mcg per unit. A 250 mcg prescription from that vial is 2.5 units at 1 mL, 5 units at 2 mL, 7.5 units at 3 mL and 10 units at 4 mL. The dose never moved. Only the number of marks it occupies did.

That is the whole reason the diluent volume is worth one minute of thought before mixing: a dose sitting on two or three marks cannot be drawn accurately, and a dose needing more than a barrel holds cannot be drawn at all. Two limits apply to the lever. The vial has to hold the water, and most small peptide vials are 2 mL or 3 mL containers; and where a pharmacy label specifies the diluent volume, that volume is part of the dispensed product, so this page becomes a check on the label rather than a choice. Altering the water in a vial a pharmacy prepared is a question for that pharmacy.

Regulatory status of compounded peptides

In the US, peptides reach patients in three ways. A few are FDA-approved drugs with a labeled indication, such as tesamorelin for HIV-associated abdominal fat and bremelanotide for hypoactive sexual desire disorder in premenopausal women; other uses of those products are off-label and clinician-directed. Others are compounded by licensed pharmacies under a prescription for an individual patient. And some may not be compounded at all. Section 503A lets a pharmacy compound from a bulk substance only if that substance has a USP or NF monograph, is a component of an FDA-approved drug product, or appears on the 503A bulks list. In September 2023 the FDA placed BPC-157 and several other peptides in 503A category 2, citing safety concerns including immunogenicity and impurities; its 503A category list updated April 22, 2026 removed twelve of those peptides, BPC-157 among them, from category 2 because the nominations were withdrawn by the nominators, and its safety-risk page, current as of April 22, 2026, lists them among the withdrawn nominations with the safety concerns still set out. We checked both on October 8, 2026. A withdrawn nomination is a decision by whoever nominated the substance, not an FDA finding that the substance is safe. On those FDA pages as they stood on April 22, 2026, which we read on October 8, 2026, none of those peptides was on the 503A bulks list, so none of them was a substance a licensed pharmacy could compound from bulk.

None of that changes the arithmetic on this page, but it does change what a reader should expect from a clinic. A clinic prescribing a peptide should be able to say what the compound's status is on the FDA's current pages, which pharmacy dispenses it and on what basis, and what the clinician's prescription is in micrograms. This page takes that prescription as its input and does not suggest, adjust or comment on it.

Methodology and sources

The calculator applies the dimensional analysis taught for reconstituting powdered medicines in nursing dosage calculation, as set out in Boyer's Math for Nurses, to a lyophilized peptide vial, and it is pointed at the question that comes before any dose is drawn: what concentration a given diluent volume creates and what one syringe unit then holds. Concentration in micrograms per milliliter equals the vial's milligrams times 1,000 divided by the milliliters of diluent. The volume for one dose equals the prescribed micrograms divided by that concentration, units on a U-100 syringe equal milliliters times 100, and doses per vial equals the vial's total micrograms divided by the dose, rounded down. The method assumes the powder adds no meaningful volume when it dissolves, which holds at milligram quantities, and that the whole labeled amount is in the vial, which is a question for the dispensing pharmacy rather than for arithmetic. Working from a vial that is already mixed is the general peptide calculator's job, and reading a prescription in micrograms into units is the peptide dosage calculator's.

How the numbers are produced, with the diluent volume as the variable: a 10 mg vial and a prescribed dose of 250 mcg. At 1 mL the vial holds 10,000 mcg/mL, one unit carries 100 mcg, and the dose is 0.025 mL or 2.5 units. At 2 mL it holds 5,000 mcg/mL, a unit carries 50 mcg, and the dose is 0.05 mL or 5 units. At 4 mL it holds 2,500 mcg/mL, a unit carries 25 mcg, and the dose is 0.1 mL or 10 units. Doses per vial is 40 at every one of those volumes, because 10,000 mcg divided by 250 mcg does not depend on the water. The formula registry's own example agrees on the smaller vial: 5 mg with 2 mL is 2,500 mcg/mL, a 250 mcg dose is 0.1 mL or 10 units, and that vial holds 20 doses.

The result bands read the concentration, not a clinical threshold, and they translate it into micrograms per unit because that is the figure that decides whether a dose can be measured: below roughly 5 mcg per unit a modest dose fills more than one barrel, and above roughly 100 mcg per unit a small dose lands on the first two or three marks. The 28-day limit for a punctured bacteriostatic water vial comes from the product labeling and from USP General Chapter 797 practice on multi-dose containers; the dispensing pharmacy's beyond-use date on the reconstituted vial takes precedence over it. The dose itself is entered by you from your clinician's prescription, and the page holds no dose information of its own.

Medical review: Medical review pending. Last updated October 8, 2026.

References

1. Boyer MJ. Math for Nurses: A Pocket Guide to Dosage Calculation and Drug Preparation. 9th ed. Philadelphia, PA: Wolters Kluwer; 2016.
2. United States Pharmacopeia. General Chapter 797 Pharmaceutical Compounding: Sterile Preparations. USP-NF. Rockville, MD: United States Pharmacopeial Convention; revised 2022, official November 1, 2023. https://www.usp.org/compounding/general-chapter-797
3. US Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. Content current as of April 22, 2026; checked October 8, 2026. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
4. Institute for Safe Medication Practices. ISMP guidelines for safe preparation of compounded sterile preparations. Revised 2016. Horsham, PA: Institute for Safe Medication Practices.
5. US Food and Drug Administration. Bulk drug substances nominated for use in compounding under section 503A of the Federal Food, Drug, and Cosmetic Act, category list updated May 14, 2026 (and the April 22, 2026 version recording the withdrawn nominations). Checked October 8, 2026. https://www.fda.gov/media/94155/download